Atossa Therapeutics
ATOS
#10757
Rank
โ‚น1.80 B
Marketcap
โ‚น180.38
Share price
-1.53%
Change (1 day)
157.47%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): -โ‚น371.22

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น382.25. In 2025 the company made an earnings per share (EPS) of -โ‚น377.58 a decrease over its 2024 EPS that were of -โ‚น284.12.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น371.22-1.68%
2025-โ‚น377.5832.89%
2024-โ‚น284.12-15.56%
2023-โ‚น336.4614.29%
2022-โ‚น294.4016.67%
2021-โ‚น252.34-90.86%
2020-โ‚น2,762-2.96%
2019-โ‚น2,846-63.09%
2018-โ‚น7,710-49.63%
2017-โ‚น15,309-57.87%
2016-โ‚น36,337-74.01%
2015-โ‚น1,39,798-9.18%
2014-โ‚น1,53,928-12.86%
2013-โ‚น1,76,63970.73%
2012-โ‚น1,03,46034.07%
2011-โ‚น77,168263.41%
2010-โ‚น21,234

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น624.30-263.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น951.42-348.90%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น1,147-400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น23.36-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น19.63-94.87%๐Ÿ‡บ๐Ÿ‡ธ USA